Xiaolun Sun Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Assistant Professor
faculty
Poultry Science
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Xiaolun Sun is an Assistant Professor in Poultry Science at the Arkansas Agricultural Experiment Station. His research focuses on the interplay between host-microbe interactions and immune responses, particularly concerning gastrointestinal health in poultry and its relevance to human health.
Sun's work investigates the mechanisms by which specific bacteria, such as *Clostridium perfringens* and *Salmonella Enteritidis*, influence host health. This includes studying the role of microbial metabolites, like secondary bile acids, in modulating bacterial virulence and host immune responses. He has published research examining how compounds such as sodium butyrate and natural compounds like resveratrol can impact host defense pathways, including the NF-κB signaling pathway, and affect inflammation and vascular function in models involving mice and human endothelial cells.
His research also extends to the development of strategies to prevent and control enteric diseases in poultry. This includes exploring the efficacy of vaccines based on bacterial sporulation proteins and the use of recombinant enzymes to enhance the effectiveness of antimicrobial compounds. Sun's scholarship metrics include an h-index of 21 and over 1,700 citations across 64 publications. He actively collaborates with researchers at the University of Arkansas at Fayetteville.
Metrics
- h-index: 21
- Publications: 64
- Citations: 1,746
Selected Publications
-
The Mechanistic Target of Rapamycin Mediates Clostridium perfringens-Induced Chicken Necrotic Enteritis Attenuated by Secondary Bile Acid Deoxycholic Acid (2025)
-
Identification of Salt Tolerance and Stress Response in US Department of Agriculture Tomato Germplasm at the Seedling Stage (2024)
-
Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence (2024)
-
Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence (2023)
-
Essential Oils as an Alternative to Antibiotics to Reduce the Incidence and Severity of Necrotic Enteritis in Broiler Chickens: A Short Review (2023)
-
Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens (2022)
-
Clostridium perfringens-Induced Necrotic Diseases: An Overview (2022)
-
Triterpenoid CDDO-IM protects against lipopolysaccharide-induced inflammatory response and cytotoxicity in macrophages: The involvement of the NF-κB signaling pathway (2022)
-
Natural Compound Resveratrol Attenuates TNF-Alpha-Induced Vascular Dysfunction in Mice and Human Endothelial Cells: The Involvement of the NF-κB Signaling Pathway (2021)
-
Microbiota from Specific Pathogen-Free Mice Reduces Campylobacter jejuni Chicken Colonization (2021)
-
Specific Secondary Bile Acids Control Chicken Necrotic Enteritis (2021)
-
Sodium butyrate modulates chicken macrophage proteins essential for Salmonella Enteritidis invasion (2021)
Collaboration Network
Top Collaborators
- Clostridium perfringens-Induced Necrotic Diseases: An Overview
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
Showing 5 of 8 shared publications
- Clostridium perfringens-Induced Necrotic Diseases: An Overview
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
Showing 5 of 8 shared publications
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Potent Bile Acid Microbial Metabolites Modulate Clostridium perfringens Virulence
- Microbiota from Specific Pathogen-Free Mice Reduces Campylobacter jejuni Chicken Colonization
- The Role of Immune Response and Microbiota on Campylobacteriosis
Showing 5 of 6 shared publications
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Sodium butyrate modulates chicken macrophage proteins essential for Salmonella Enteritidis invasion
- Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens
- Microbiota from Specific Pathogen-Free Mice Reduces Campylobacter jejuni Chicken Colonization
- The Mechanistic Target of Rapamycin Mediates Clostridium perfringens-Induced Chicken Necrotic Enteritis Attenuated by Secondary Bile Acid Deoxycholic Acid
- Specific Secondary Bile Acids Control Chicken Necrotic Enteritis
- Sodium butyrate modulates chicken macrophage proteins essential for Salmonella Enteritidis invasion
- Recombinant Bile Salt Hydrolase Enhances the Inhibition Efficiency of Taurodeoxycholic Acid against Clostridium perfringens Virulence
- The Mechanistic Target of Rapamycin Mediates Clostridium perfringens-Induced Chicken Necrotic Enteritis Attenuated by Secondary Bile Acid Deoxycholic Acid
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Supplementary Materials and Methods, Supplementary Figures 1 through 5, and Supplementary Tables 1 through 3 from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
- Data from Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Similar Researchers
Based on overlapping research topics